about
Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists.The past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review.Chronic sinusitis pathophysiology: the role of allergyMolecular and cellular staging for the severity of chronic rhinosinusitisChronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory diseaseAspirin desensitization for chronic hyperplastic sinusitis, nasal polyposis, and asthma triadAspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthmaExpression of leukotriene C4 synthase and plasminogen activator inhibitor 1 gene promoter polymorphisms in sinusitisBiological effects of leukotriene E4 on eosinophilsThe influence of diesel exhaust particles on mononuclear phagocytic cell-derived cytokines: IL-10, TGF-beta and IL-1 betaAspirin-exacerbated respiratory disease: Prevalence, diagnosis, treatment, and considerations for the futureLack of Efficacy of Symptoms and Medical History in Distinguishing the Degree of Eosinophilia in Nasal Polyps.Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection - a randomised controlled trial.Immune Responses in Rhinovirus-Induced Asthma Exacerbations.Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.Chronic rhinosinusitis phenotypes.Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.The immunology of asthma: Asthma phenotypes and their implications for personalized treatment.Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease.Allergic Fungal Rhinosinusitis.Non-specific airway hyperreactivity in asthma: a clinical correlate to … what exactly?Management of rhinosinusitis during pregnancy: systematic review and expert panel recommendations.Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticariaChronic Rhinosinusitis: More Than Just "Asthma of the Upper Airway"Fatal Coxsackie meningoencephalitis in a patient with B-cell lymphopenia and hypogammaglobulinemia following rituximab therapy.Factors driving the aspirin exacerbated respiratory disease phenotype.Immune surveillance by rhinovirus-specific circulating CD4+ and CD8+ T lymphocytes.Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer.The role of leukotrienes in upper and lower airway inflammation and the implications for treatment.Cysteinyl leukotrienes in chronic hyperplastic rhinosinusitis.Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma.2. Cytokines and chemokines.5. Genetics of hypersensitivity.Sinus computed tomography scan and markers of inflammation in vocal cord dysfunction and asthmaCharacterization of interleukin-4-stimulated nasal polyp fibroblasts.Allergic rhinitis: systemic inflammation and implications for management.The role of allergy in chronic rhinosinusitis.Failure of itraconazole to prevent T-helper type 2 cell immune deviation: Implications for chronic rhinosinusitis.Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory diseaseCase fatality and population mortality associated with anaphylaxis in the United States.
P50
Q24791820-96B0E40A-204D-4E2E-9657-D211C8BDDEBEQ26775861-3BC4A03F-FB6D-4C92-92FD-74DB56620B98Q27692520-792BA331-2214-456F-A7B7-CC4BE318C92EQ28171337-3527E1C6-4185-40E3-ACE4-75EF826EFF5CQ28182005-5D9C6CDC-B782-4996-8151-94AF3C4044B4Q28189753-2E490618-3141-46B9-92D3-340C27336F37Q28193250-C78BB81C-0C42-48E8-AABD-AD06B085E4E4Q28201078-BC568046-869A-49D5-831F-0C2CA04CEF5FQ28238927-D9F741C8-16F3-4C15-896B-E48E188AE35AQ28365966-214A6A29-AB97-46C0-A758-8D5D2BFDC9A8Q30238776-2E84A3C4-48C7-474B-8BF1-ACB32A8E8C4DQ30252446-88A678A6-1AD0-4C3C-8D64-D2A31279EEBAQ30252865-DF8A2604-91A9-413B-9332-EA734B5393D8Q30275562-D06904E8-709D-489B-83A1-BDE240EEF1ACQ30275780-818596AD-6660-4BC3-ADF0-9B25F260FE42Q30275962-ADC39084-E488-4D61-98BF-8FEE6ED8685BQ30276174-FEB00204-3810-4BA7-9333-6E816BE44C38Q30276175-F48008D6-7EF8-474D-BA84-7265808854EAQ30276354-93F5348C-8842-44EA-B584-0F8CEAC6CE24Q30276392-24E4E660-4FBD-4699-AD08-E96275E45B37Q30277662-96BB250C-7599-4B44-A75F-535EE9AAEFC0Q30277690-25841D7B-C710-4FF5-B104-8C5DB2C83029Q30277818-F3192C2C-0480-4B80-B2A2-581C0B2F30DFQ30278686-F5239629-89AD-4197-9100-8C18C6A1A3DEQ30279230-842A036D-5D53-43D3-BDE9-A96EAED7AB9DQ30300955-4AAF9BCF-56A9-457A-87F8-ADB353808CCBQ30300966-D91F1C58-CFFB-4422-AE82-A2A5981BFD1CQ30308940-7DF1BB16-14DB-434F-94F5-445952174B29Q30309287-B08BEEFF-9B0C-430D-9215-42D7E5B9C73CQ30310359-6D677B90-A5FD-4DA6-88D2-A06AFE8FF7BCQ30310528-9C5DE634-B2AE-401A-8D55-33948FE5DBE3Q30310536-AD6DF6D3-DA64-4B34-9C55-DF37BF5E4BFBQ30310538-B2DF88F2-E9FD-4548-913E-4A74E0F0D9B0Q30310724-D72A909D-2CA6-4966-AA86-10B858BA50E2Q30311131-04A4BC36-C911-467A-A255-A132674CF8E8Q30311991-B8B8A789-1935-4927-AF9A-5FC31176F2ACQ30312288-27ABBA7A-4F72-4822-8438-F6D2C90D7F08Q30355164-0262A875-B5F0-49E6-ACA2-9A5A297B61B3Q30384450-F43E53E0-01CB-4863-AC80-20ECD62EE4C4Q30406068-90136E06-C6E8-4357-BCF1-9234380E947D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Larry C. Borish
@ast
Larry C. Borish
@en
Larry C. Borish
@es
Larry C. Borish
@nl
type
label
Larry C. Borish
@ast
Larry C. Borish
@en
Larry C. Borish
@es
Larry C. Borish
@nl
altLabel
Borish
@en
L Borish
@en
L C Borish
@en
L. Borish
@en
L. C. Borish
@en
Larry Borish
@en
Larry C Borish
@en
prefLabel
Larry C. Borish
@ast
Larry C. Borish
@en
Larry C. Borish
@es
Larry C. Borish
@nl
P106
P21
P31
P496
0000-0002-8298-8184